Illumina and Labcorp expand precision oncology testing collaboration
Go back to Illumina and Labcorp expand precision oncology testing collaboration| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 164.93 +3.55 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.38 | 52 Week High | $196.47 | |||
| Open | $160.60 | 52 Week Low | $127.10 | |||
| Day High | $166.63 | P/E | 183.26 | |||
| Day Low | $159.98 | EPS | $0.90 | |||
| Volume | 2,062,649 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 258.59 +4.16 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $254.43 | 52 Week High | $141.32 | |||
| Open | $257.68 | 52 Week Low | $97.79 | |||
| Day High | $260.32 | P/E | 41.37 | |||
| Day Low | $256.43 | EPS | $6.25 | |||
| Volume | 445,221 | |||||
